SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Update

Teva to buy Allergan's generics biz for $40.5bn

Teva has struck a deal to buy Allergan’s generics business a week after its persistent attempts to acquire Mylan fell through.

Sandoz details plant closures

Less than a year to risk assess excipients: IPEC Europe develops 'how to' guide

IPEC Europe has reminded drugmakers they have less than a year to risk assess all excipients used in their products under recently introduced EU rules.

EU and Swiss regulators strengthen ties with confidentiality agreement

A confidential information exchange agreement will strengthen the relationship between the EMA and Swiss regulators and could save on resources, the agencies say.

Sandoz shutters German and Indian production sites

Sandoz has revealed it will close three manufacturing sites in Germany and India.

Capsugel expanding Encap plant on rising HPAPI demand

Capsugel is doubling the size of a facility in Scotland to support demand for the encapsulating of drugs containing high-potency active pharmaceutical ingredients (HPAPIs).

Funds worth €3.5tr back Alltrials, but none promise to pull cash from drug firms that don't

Investor backing puts transparency on the pharma agenda says SenseAboutScience, even though none of the funds pledging support for Alltrials have committed to pull investment from drug firms that disagree.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...